30|day mortality after systemic anticancer treatment for breast and ...

30-day mortality after systemic anticancer treatment for breast and ...

The aim of this first study based on the SACT dataset was to establish national 30-day mortality benchmarks for breast and lung cancer patients receiving SACT ...

Thirty-Day Mortality Following Systemic Anticancer Therapy

For curative SACTs, the 30-day mortality was less than 2%, except for brain, ovarian and prostate cancers (3.2%, 5.4% and 7.7% for the improved ...

30-day mortality after systemic anticancer treatment for breast and ...

The Systemic Anti-Cancer Therapy (SACT) dataset collated by Public. Health England allows the assessment of factors affecting 30-day mortality ...

Thirty-Day Mortality Following Systemic Anticancer Therapy

For curative SACTs, the 30-day mortality was less than 2%, except for brain, ovarian and prostate cancers (3.2%, 5.4% and 7.7% for the improved indicator, ...

30-day mortality after systemic anti-cancer therapy (SACT)

Among the most commonly treated cancers, those with more than 1,000 patients treated in 2023, the highest SACT 30-day mortality was recorded for ...

Trust-level 30-day mortality after systemic anticancer treatment for ...

we described the use of NHS systemic anticancer therapy (SACT) information on a national scale to examine deaths among lung and breast ...

Thirty-Day Mortality Following Systemic Anticancer Therapy - PubMed

We defined an indicator adapted to the clinical context evaluating 30-day mortality following SACT. This indicator can be used to identify ...

30-day mortality post-Systemic Anti-Cancer Therapy - NHS Digital

The 30-day mortality post-SACT CMAR report includes patients diagnosed with cancer in England and treated with SACT, with each report focusing on a defined ...

Chemotherapy for breast and lung cancer: 30-day mortality - GOV.UK

Trust-level 30-day mortality after systemic anticancer treatment for breast and lung cancer in England. Ref: PHE gateway ref 2016250. PDF ...

30-day mortality after the start of systemic anticancer therapy for lung ...

Systemic treatment is the standard treatment for unresectable stage III and IV lung cancer. Nevertheless, a 5–10% death rate has been described within 30 ...

Thirty-Day Mortality Following Systemic Anticancer Therapy

For lung, pancreatic and prostate cancer, patients were pre- dominantly given palliative SACTs (87%, 88% and 98%, respectively). In contrast, breast cancer ...

Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment ...

1072 patients were identified. Annual 30-day mortality rate after palliative-intent SACT for lung cancer ranged between 9% and 15%, with significant variance ...

30-day mortality after systemic anticancer treatment for breast and ...

Medicine and Dentistry · Observational Study · Lung Cancer · Breast Cancer · Non Small Cell Lung Cancer · Cancer Treatment · Mortality Rate · Public Health · Clinical ...

Dynamic Risk Prediction of 30-Day Mortality in Patients With ...

Administering systemic anticancer treatment (SACT) to patients near death can negatively affect their health-related quality of life.

Thirty-Day Mortality After Curative and Palliative Anti-Cancer ...

Fifty-nine (3.5%) patients died within 30 days of receiving anti-cancer treatment. Of them, 9 (0.3%) were treated with curative intent, and 50 ( ...

2143P Mortality within 30 days after last dose of intravenous ...

The 30-day mortality rate after systemic anticancer treatment was 7.0% (n = 136) in the entire patient group. While the 30-day mortality rate for patients who ...

Intensity of end-of-life health care and mortality after systemic anti ...

0.8 and 2.5% of SACT patients had died within 14 and 30 days after the treatment decision, respectively, compared with the 24 and 41% in the no- ...

Thirty‐day mortality after systemic anticancer treatment as a real ...

One patient died receiving curative intent SACT. More deaths occurred in SACT-naïve patients and during the first two cycles of therapy. Of the ...

30-day mortality after systemic anticancer treatment for breast and ...

We identified trusts with mortality rates in excess of the 95% control limits; this included seven for curative breast cancer, four for ...

Mortality Within 30 Days of Administration of a Systemic Anticancer ...

We registered 1056 patients who received systemic anticancer treatment, 31 died within 30 days of administration, giving a mortality rate of 2.9%.